title: Letter: infliximab therapy in inflammatory bowel disease patients after liver transplantation.
authors.forename: A
authors.initials: A
authors.lastname: Indriolo
authors.forename: S
authors.initials: S
authors.lastname: Fagiuoli
authors.forename: L
authors.initials: L
authors.lastname: Pasulo
authors.forename: G
authors.initials: G
authors.lastname: Fiorino
authors.forename: S
authors.initials: S
authors.lastname: Danese
authors.forename: P
authors.initials: P
authors.lastname: Ravelli
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D000069285:Infliximab; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D055815:Young Adult
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab